The SARS-CoV-2 pandemic has become one of the most serious public health issues. The adaptive immune system has a fundamental role in the recognition and destruction of the virus.
Join us for a webinar with Máté Manczinger (Project Leader at Csaba Pál Laboratory, Biological Research Centre, Szeged, Hungary) who will be summarizing our current knowledge about the role of HLA molecules in the susceptibility and clinical course of COVID-19. He will also shortly present their research on the topic.
Máté Manczinger (Project Leader at Csaba Pál Laboratory, Biological Research Centre, Szeged, Hungary)
Agenda:
🔸 The clinical course of COVID-19 in the light of adaptive immune recognition
🔸 Summary of what we currently know about the role of HLA in the development and clinical course of COVID-19
🔸 Our research about the HLA-presentation of SARS-CoV-2
🔸 Q&A
About the speaker:
Máté Manczinger has been doing research in computational immunology for 5 years. His research group focuses on the role of antigen presentation in susceptibility to infections, autoimmunity and cancer. He works as a project leader at Csaba Pál Laboratory at the Biological Research Centre, Szeged and as an assistant professor at the Department of Dermatology and Allergology, University of Szeged, Hungary.
Please note that participation in this educational program provides 0.15 Continued Education Credits (CECs) accredited by the American Board of Histocompatibility and Immunogenetics (ABHI).
We are looking forward to seeing you remotely on our next sessions in the near future. If you have any questions, please contact us directly at sales@omixon.com
